INTERNET 2.0

TODA LA INFORMACION DE LA RED

  • Full Screen
  • Wide Screen
  • Narrow Screen
  • Increase font size
  • Default font size
  • Decrease font size
HAZ CLICK EN " E-mail " PARA ENVIAR ESTA INFORMACION A UN AMIGO/A:
 E-mail
PORTAL DE PSICOLOGIA Y AUTOAYUDA   

 BIBLIOGRAFIA CUIDADOS PALIATIVOS  


  



  BiBliografía de los Cuidados Paliativos

  • Estrategia en Cuidados Paliativos. Sistema Nacional de Salud. Madrid: Ministerio de Sanidad y Consumo; 2007.
  • World Health Organization. WHO definition of palliative care. Disponible en: http://www.who.int/cancer/palliative/definition/en/ [Acceso marzo 2007].
  • Institute for Clinical Systems Improvement (ICSI). Heath Care Guideline: Palliative Care. Bloomington (MN): Institute for Clinical Systems Improvement (ICSI); 2007.
  • Guidelines for a Palliative Approach in Residential Aged care. Canberra: The National Palliative Care Program. National Health and Medical Research Council; 2006.
  • Improving Supportive and Palliative Care for Adults with Cancer. London: National Institute for Clinical Evidence; 2004.
  • Finlay IG, Higginson IJ, Goodwin DM, Cook AM, Edwards AGK, Hood K, et al. Palliative care in hospital, hospice, at home: Results from a systematic review. Annals of Oncology. 2002;13(SUPPL. 4):257-64.
  • Higginson IJ, Finlay I, Goodwin DM, Cook AM, Hood K, Edwards AGK, et al. Do hospital-based palliative teams improve care for patients or families at the end of life? Journal of Pain & Symptom Management. 2002;23(2):96-106.
  • Smeenk FW, van Haastregt JC, de Witte LP, Crebolder HF. Effectiveness of home care programmes for patients with incurable cancer on their quality of life and time spent in hospital: systematic review. BMJ. 1998;316(7149):1939-44.
  • Higginson IJ, Finlay IG, Goodwin DM, Hood K, Edwards AGK, Cook A, et al. Is there evidence that palliative care teams alter end-of-life experiences of patients and their caregivers? Journal of Pain & Symptom Management. 2003;25(2):150-68.
  • Herrera E, Rocafort J, Cuervo Pinna MA, Redondo Moralo MJ. Primer nivel asistencial en cuidados paliativos: evolución del contenido de la cartera de servicios de atención primaria y criterios de derivación al nivel de soporte. Aten Primaria. 2006;38 Suppl 2:85-92.
  • Glare P, Christakis N. Predicting survival in patients with advanced disease. In: Doyle D, Hanks G, Chreney N, Calman K, editors. Oxford Textbook of Palliative Medicine. Third ed. Oxford: Oxford University Press; 2004.
  • Glare P, Virik K, Jones M, Hudson M, Eychmuller S, Simes J, et al. A systematic review of physicians’ survival predictions in terminally ill cancer patients. BMJ. 2003;327(7408):195.
  • Vigano A, Dorgan M, Buckingham J, Bruera E, Suarez-Almazor ME. Survival prediction in terminal cancer patients: A systematic review of the medical literature. Palliative Medicine. 2000;14(5):363-74.
  • Maltoni M, Nanni O, Pirovano M, Scarpi E, Indelli M, Martini C, et al. Successful Validation of the Palliative Prognostic Score in Terminally Ill Cancer Patients. Journal of Pain and Symptom Management. 1999;17(4):240-7.
  • Pirovano M, Maltoni M, Nanni O, Marinari M, Indelli M, Zaninetta G, et al. A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative Care. J Pain Symptom Manage. 1999;17(4):231-9.
  • Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmueller S, et al. Prognostic Factors in Advanced Cancer Patients: Evidence-Based Clinical Recommendations--A Study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol. 2005;23(25):6240-8.
  • Glare PA, Eychmueller S, McMahon P. Diagnostic Accuracy of the Palliative Prognostic Score in Hospitalized Patients With Advanced Cancer. J Clin Oncol. 2004;22(23):4823-8.
  • Coventry PA, Grande GE, Richards DA, Todd CJ. Prediction of appropriate timing of palliative care for older adults with non-malignant life-threatening disease: A systematic review. Age & Ageing. 2005;34(3):218-27.
  • Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, et al. The Seattle Heart Failure Model: Prediction of Survival in Heart Failure. Circulation. 2006;113(11):1424-33.
  • Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33(2):464-70.
  • Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease. N Engl J Med. 2004;350(10):1005-12.
  • Walter LC, Brand RJ, Counsell SR, Palmer RM, Landefeld CS, Fortinsky RH, et al. Development and Validation of a Prognostic Index for 1-Year Mortality in Older Adults After Hospitalization. JAMA. 2001;285(23):2987-94.
  • Fellowes D, Wilkinson S, Moore P. Communication skills training for health care professionals working with cancer patients, their families and/or carers. Cochrane Database Syst Rev. 2004;(2):CD003751.
  • Centeno CC, Nuñez Olarte JM. Estudios sobre la comunicación del diagnóstico de cáncer en España. Med Clin (Barc ). 1998;110(19):744-50.
  • Parker SM, Clayton JM, Hancock K, Walder S, Butow PN, Carrick S, et al. A Systematic Review of Prognostic/End-of-Life Communication with Adults in the Advanced Stages of a Life-Limiting Illness: Patient/Caregiver Preferences for the Content, Style, and Timing of Information. Journal of Pain and Symptom Management. 2007;34(1):81-93.
  • McPherson CJ, Higginson IJ, Hearn J. Effective methods of giving information in cancer: a systematic literature review of randomized controlled trials. J Public Health Med. 2001;23(3):227-34.
  • Bruera E, Neumann CM, Mazzocato C, Stiefel F, Sala R. Attitudes and beliefs of palliative care physicians regarding communication with terminally ill cancer patients. Palliat Med. 2000;14(4):287-98.
  • Stewart MA. Effective physician-patient communication and health outcomes: a review. CMAJ. 1995;152(9):1423-33.
  • Mills ME, Sullivan K. The importance of information giving for patients newly diagnosed with cancer: a review of the literature. J Clin Nurs. 1999;8(6):631-42.
  • Fallowfield L. Communication with the patient and family in palliative medicine. In: Doyle D, Hanks G, Chreney N, Calman K, editors. Oxford Textbook of Palliative Medicine. Third ed. Oxford: Oxford University Press; 2004.
  • Buckman R. Breaking bad news: why is it still so difficult? Br Med J (Clin Res Ed). 1984;288(6430):1597-9.
  • Rabow MW, McPhee SJ. Beyond breaking bad news: how to help patients who suffer. West J Med. 1999;171(4):260-3.
  • Back AL, Arnold RM, Baile WF, Fryer-Edwards KA, Alexander SC, Barley GE, et al. Efficacy of communication skills training for giving bad news and discussing transitions to palliative care. Arch Intern Med. 2007;167(5):453-60.
  • Delvaux N, Merckaert I, Marchal S, Libert Y, Conradt S, Boniver J, et al. Physicians’ communication with a cancer patient and a relative: a randomized study assessing the efficacy of consolidation workshops. Cancer. 2005;103(11):2397-411.
  • Razavi D, Merckaert I, Marchal S, Libert Y, Conradt S, Boniver J, et al. How to optimize physicians’ communication skills in cancer care: results of a randomized study assessing the usefulness of posttraining consolidation workshops. J Clin Oncol. 2003;21(16):3141-9.
  • Barbero J. El derecho del paciente a la información: el arte de comunicar. Anales del Sistema Sanitario de Navarra. Suplementos. 2006;29(Supl.3):19-27.
  • Alonso BA. Atención a la familia. Aten Primaria. 2006;38 Suppl 2:14-20.
  • Astudillo W, Clavé E, Urdaneta E. Necesidades psicosociales en la terminalidad. 1ª edición. En: Sociedad Vasca de Cuidados Paliativos, editor. San Sebastián; 2001.
  • Arce Garcia MC. Problemas éticos en cuidados paliativos. Aten Primaria. 2006;38 Suppl 2:79-84.
  • Fried TR, O’leary J, Van NP, Fraenkel L. Inconsistency over time in the preferences of older persons with advanced illness for life-sustaining treatment. J Am Geriatr Soc. 2007;55(7):1007-14.
  • Shalowitz DI, Garrett-Mayer E, Wendler D. The accuracy of surrogate decision makers: a systematic review. Arch Intern Med. 2006;166(5):493-7.
  • Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage. 2006;31(1):58-69.
  • Verger E, Conill C, Pedro A, Chicote S, Salamero M, de AP, et al. Cuidados paliativos en pacientes oncológicos. Frecuencia y prioridad de síntomas. Med Clin (Barc). 1992;99(15):565-7.
  • Hanks G, Robers C, Davoes A. Principles of drug use in palliative medicine. In: Doyle D, Hanks G, Chreney N, Calman K, editors. Oxford Textbook of Palliative Medicine. Third ed. Oxford: Oxford University Press; 2004.
  • Kirkova J, Davis MP, Walsh D, Tiernan E, O’leary N, LeGrand SB, et al. Cancer symptom assessment instruments: a systematic review. J Clin Oncol. 2006;24(9):1459-73.
  • Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991;7(2):6-9.
  • Vervest AC, Schimmel GH. Taxonomy of pain of the IASP. Pain. 1998;34(3):318-21.
  • Breitbart W, Payne D, Passik SD. Psychological and psychiatric interventions in pain control. In: Doyle D, Hanks G, Chreney N, Calman K, editors. Oxford Textbook of Palliative Medicine. Third ed. Oxford: Oxford University Press; 2004.
  • Control of pain in patients with cancer. Draft Guideline. Edinburgh: Scottish Intercollegiate Guidelines Network (SIGN); 2007.
  • Jadad AR, Browman GP. The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation. JAMA. 1995;274(23):1870-3.
  • Azevedo Sao Leao FK, Kimura M, Jacobsen TM. The WHO analgesic ladder for cancer pain control, twenty years of use. How much pain relief does one get from using it? Support Care Cancer. 2006;14(11):1086-93.
  • Miguel R. Interventional treatmente of cancer Pain:The Fourth Step in the World Health Organization Analgesic Ladder? Cancer Control. 2000;7(2):149-56.
  • McNicol E, Strassels SA, Goudas L, Lau J, Carr DB. NSAIDS or paracetamol, alone or combined with opioids, for cancer pain. Cochrane Database Syst Rev. 2005;(1):CD005180.
  • Nicholson AB. Methadone for cancer pain. Cochrane Database Syst Rev. 2004;(2):CD003971.
  • Reid CM, Martin RM, Sterne JAC, Davies AN, Hanks GW. Oxycodone for cancer-related pain: Meta-analysis of randomized controlled trials. Archives of Internal Medicine. 2006;166(8):837-43.
  • Wiffen PJ, Edwards JE, Barden J, McQuay HJ. Oral morphine for cancer pain. Cochrane Database Syst Rev. 2003;(4):CD003868.
  • Moore RA, McQuay HJ. Prevalence of opioid adverse events in chronic nonmalignant pain: systematic review of randomised trials of oral opioids. Arthritis Res Ther. 2005;7(5):R1046-R1051.
  • Cherny N, Ripamonti C, Pereira J, Davis C, Fallon M, McQuay H, et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol. 2001;19(9):2542-54.
  • McNicol E, Horowicz-Mehler N, Fisk RA, Bennett K, Gialeli-Goudas M, Chew PW, et al. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain. 2003;4(5):231-56.
  • Mercadante S, Bruera E. Opioid switching: a systematic and critical review. Cancer Treat Rev. 2006;32(4):304-15.
  • Quigley C. Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev. 2004;CD004847.
  • Allan L, Hays H, Jensen NH, de-Waroux BL, Bolt M, Donald R, et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ. 2001;322:1154-8.
  • Ahmedzai S, Brooks D. Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTSFentanyl Comparative Trial Group. Journal of pain and symptom management. 1997;13:254-61.
  • Lussier D, Portenoy RK. Adjuvant analgesics in pain management. In: Doyle D, Hanks G, Chreney N, Calman K, editors. Oxford Textbook of Palliative Medicine. Third ed. Oxford: Oxford University Press; 2004.
  • Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2005;(3):CD005454.
  • Lee H, Schmidt K, Ernst E. Acupuncture for the relief of cancer-related pain- -a systematic review. Eur J Pain. 2005;9(4):437-44.
  • Cepeda MS, Carr DB, Lau J, Alvarez H. Music for pain relief. Cochrane Database Syst Rev. 2006;(2):CD004843.
  • Fellowes D, Barnes K, Wilkinson S. Aromatherapy and massage for symptom relief in patients with cancer. Cochrane Database Syst Rev. 2004;(2): CD002287.
  • Carr DB, Goudas LC, Balk EM, Bloch R, Ioannidis JP, Lau J. Evidence report on the treatment of pain in cancer patients. J Natl Cancer Inst Monogr. 2004;(32):23-31.
  • Pan CX, Morrison RS, Ness J, Fugh-Berman A, Leipzig RM. Complementary and alternative medicine in the management of pain, dyspnea, and nausea and vomiting near the end of life. A systematic review. J Pain Symptom Manage. 2000;20(5):374-87.
  • Lafferty WE, Downey L, McCarty RL, Standish LJ, Patrick DL. Evaluating CAM treatment at the end of life: a review of clinical trials for massage and meditation. Complement Ther Med. 2006;14(2):100-12.
  • Wareham D. Postherpetic neuralgia. Clin Evid. 2005;(14):1017-25.
  • Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev. 2005;(3): CD001133.
  • Wiffen PJ, McQuay HJ, Edwards JE, Moore RA. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev. 2005;(3):CD005452.
  • Duhmke RM, Cornblath DD, Hollingshead JR. Tramadol for neuropathic pain. Cochrane Database Syst Rev. 2004;(2):CD003726.
  • Eisenberg E, McNicol E, Carr DB. Opioids for neuropathic pain. Cochrane Database Syst Rev. 2006;3:CD006146.
  • Wong Mc, Chung JWY, Wong TKS. Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. BMJ. 2007;335(7610):87.
  • Mason L, Moore RA, Derry S, Edwards JE, McQuay HJ. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ. 2004;328(7446):991.
  • Zeppetella G, Ribeiro MD. Opioids for the management of breakthrough (episodic) pain in cancer patients. Cochrane Database Syst Rev. 2006;(1): CD004311.
  • Coluzzi PH, Schwartzberg L, Conroy JD, Charapata S, Gay M, Busch MA, et al. Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Pain. 2001;91(1-2):123-30.
  • Martinez-Zapata MJ, Roque M, onso-Coello P, Catala E. Calcitonin for metastatic bone pain. Cochrane Database Syst Rev. 2006;3:CD003223.
  • Wong R, Wiffen PJ. Bisphosphonates for the relief of pain secondary to bone metastases. Cochrane Database Syst Rev. 2002;(2):CD002068.
  • Ross JR, Saunders Y, Edmonds PM, Patel S, Broadley KE, Johnston SRD. Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer. BMJ. 2003;327(7413):469.
  • Yuen KK, Shelley M, Sze WM, Wilt T, Mason MD. Bisphosphonates for advanced prostate cancer. Cochrane Database Syst Rev. 2006;(4):CD006250.
  • Pavlakis N, Schmidt R, Stockler M. Bisphosphonates for breast cancer. Cochrane Database Syst Rev. 2005;(3):CD003474.
  • McQuay HJ, Collins SL, Carroll D, Moore RA. Radiotherapy for the palliation of painful bone metastases. Cochrane Database Syst Rev. 2000;(2): CD001793.
  • Wai MS, Mike S, Ines H, Malcolm M. Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a systematic review of the randomised trials. Cochrane Database Syst Rev. 2004;(2):CD004721.
  • Chow E, Harris K, Fan G, Tsao M, Sze WM. Palliative Radiotherapy Trials for Bone Metastases: A Systematic Review. J Clin Oncol. 2007;25(11):1423-36.
  • Roque M, Martinez MJ, Alonso P, Catala E, Garcia JL, Ferrandiz M. Radioisotopes for metastatic bone pain. Cochrane Database Syst Rev. 2003;(4): base CD003347.
  • Finlay IG, Mason MD, Shelley M. Radioisotopes for the palliation of metastatic bone cancer: a systematic review. The Lancet Oncology. 2005;6(6):392-400.
  • Sweeney C, Neuenschwnader H, Bruera E. Fatigue and asthenia. In: Doyle D, Hanks G, Chreney N, Calman K, editors. Oxford Textbook of Palliative Medicine. Third ed. Oxford: Oxford University Press; 2004.
  • Mock V. Evidence-based treatment for cancer-related fatigue. J Natl Cancer Inst Monogr. 2004;(32):112-8.
  • Bohlius J, Wilson J, Seidenfeld J, Piper M, Schwarzer G, Sandercock J, et al. Erythropoietin or darbepoetin for patients with cancer. Cochrane Database Syst Rev. 2006;3:CD003407.
  • Del Fabbro E, Dalal S, Bruera E. Symptom control in palliative care--Part II: cachexia/anorexia and fatigue. J Palliat Med. 2006;9(2):409-21.
  • Yavuzsen T, Davis MP, Walsh D, LeGrand S, Lagman R. Systematic review of the treatment of cancer-associated anorexia and weight loss. J Clin Oncol. 2005;23(33):8500-11.
  • Bruera E, Valero V, Driver L, Shen L, Willey J, Zhang T, et al. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo- controlled trial. J Clin Oncol. 2006;24(13):2073-8.
  • Fainsinger RL, Bruera E. When to treat dehydration in a terminally ill patient? Support Care Cancer. 1997;5(3):205-11.
  • Dalal S, Bruera E. Dehydration in cancer patients: to treat or not to treat. J Support Oncol. 2004;2(6):467-79,
  • Viola RA, Wells GA, Peterson J. The effects of fluid status and fluid therapy on the dying: a systematic review. J Palliat Care. 1997;13(4):41-52.
  • Turner T, Cassano AM. Subcutaneous dextrose for rehydration of elderly patients--an evidence-based review. BMC Geriatr. 2004;4:2.
  • Rochon PA, Gill SS, Litner J, Fischbach M, Goodison AJ, Gordon M. A systematic review of the evidence for hypodermoclysis to treat dehydration in older people. J Gerontol A Biol Sci Med Sci. 1997;52(3):M169-M176.
  • Chan K, Sham M, Tse D, Thorsen A. Palliative medicine in malignant respiratory disease. En: Doyle D, Hanks G, Chreney N, Calman K, editors. Oxford Textbook of Palliative Medicine. Third ed. Oxford: Oxford University Press; 2004.
  • Congleton J, Muers MF. The incidence of airflow obstruction in bronchial carcinoma, its relation to breathlessness, and response to bronchodilator therapy. Respiratory Medicine. 1995;89(4):291-6.
  • Dorman S, Byrne A, Edwards A. Which measurement scales should we use to measure breathlessness in palliative care? A systematic review. Palliat Med. 2007;21(3):177-91.
  • Gallagher R. An approach to dyspnea in advanced disease. Can Fam Physician. 2003;49:1611-6.
  • Gallagher R, Roberts D. A systematic review of oxygen and airflow effect on relief of dyspnea at rest in patients with advanced disease of any cause. Journal of Pain & Palliative Care Pharmacotherapy. 2004;18(4):3-15.
  • Booth S, Wade R, Johnson M, Kite S, Swannick M, Anderson H. The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine. Respir Med. 2004;98(1):66-77.
  • Jennings A-L, Davies AN, Higgins JPT, Gibbs JSR, Broadley KE. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002;57(11):939-44.
  • Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ. 2003;327(7414):523-8.
  • Viola R, Kiteley C, Lloyd N, Mackay JA, Wilson R, and the Supportive Care Guidelines Group. The Management of Dyspnea in Cancer Patients: A Clinical Practice Guideline. A Quality Initiative of the Program in Evidence-based Care (PEBC). Disponible en: www.cancercare.on.ca/ [accedido en: septiembre 2007]
  • Navigante AH, Cerchietti LCA, Castro MA, Lutteral MA, Cabalar ME. Midazolam as Adjunct Therapy to Morphine in the Alleviation of Severe Dyspnea Perception in Patients with Advanced Cancer. Journal of Pain and Symptom Management. 2006;31(1):38-47.
  • Eng D. Management guidelines for motor neurone disease patients on noninvasive ventilation at home. Palliat Med. 2006;20(2):69-79.
  • Homsi J, Walsh D, Nelson KA. Important drugs for cough in advanced cancer. Support Care Cancer. 2001;9(8):565-74.
  • Estfan B, LeGrand S. Management of cough in advanced cancer. J Support Oncol. 2004;2(6):523-7.
  • Kvale PA. Chronic cough due to lung tumors: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 Suppl):147S-53S.
  • Luporini G, Barni S, Marchi E, Daffonchio L. Efficacy and safety of levodropropizine and dihydrocodeine on nonproductive cough in primary and metastatic lung cancer. Eur Respir J. 1998;12(1):97-101.
  • Moroni M, Porta C, Gualtieri G, Nastasi G, Tinelli C. Inhaled sodium cromoglycate to treat cough in advanced lung cancer patients. British Journal of Cancer. 1996;74:309-11.
  • Braman SS. Chronic Cough Due to Chronic Bronchitis: ACCP Evidence-Based Clinical Practice Guidelines. Chest. 2006;129(1_suppl):104S-115.
  • Rowell NP, Gleeson FV. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus. Cochrane Database Syst Rev. 2001;(4):CD001316.
  • Uberoi R. Quality assurance guidelines for superior vena cava stenting in malignant disease. Cardiovasc Intervent Radiol. 2006;29(3):319-22.
  • Centeno C, Sanz A, Bruera E. Delirium in advanced cancer patients. Palliat Med. 2004;18(3):184-94.
  • Casarett DJ, Inouye SK, for the American College of Physicians-American Society of Internal Medicine End-of-Life Care Consensus Panel*. Diagnosis and Management of Delirium near the End of Life. Ann Intern Med. 2001;135(1):32-40.
  • Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990;113(12):941-8.
  • Jackson KC, Lipman AG. Drug therapy for delirium in terminally ill patients. Cochrane Database Syst Rev. 2004;(2):CD004770.
  • Hirst A, Sloan R. Benzodiazepines and related drugs for insomnia in palliative care. Cochrane Database Syst Rev. 2002;(4):CD003346.
  • Smith MT, Perlis ML, Park A, Smith MS, Pennington J, Giles DE, et al. Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry. 2002;159(1):5-11.
  • Morgan K, Dixon S, Mathers N, Thompson J, Tomeny M. Psychological treatment for insomnia in the regulation of long-term hypnotic drug use. Health Technol Assess. 2004;8(8):iii-68.
  • Breitbart W, Chochinov HM, Passik SD. Psychiatric symptoms in palliative medicine. In: Doyle D, Hanks G, Chreney N, Calman K, editors. Oxford Textbook of Palliative Medicine. Third ed. Oxford: Oxford University Press; 2004.
  • Jackson KC, Lipman AG. Drug therapy for anxiety in palliative care. Cochrane Database Syst Rev. 2004;(1):CD004596.
  • Osborn RL, Demoncada AC, Feuerstein M. Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: meta-analyses. Int J Psychiatry Med. 2006;36(1):13-34.
  • Edwards AG, Hailey S, Maxwell M. Psychological interventions for women with metastatic breast cancer. Cochrane Database Syst Rev. 2004;(2): CD004253.
  • Chochinov HM, Holland JC. Handbook of psycho-oncolgy:Psycological care of the patient with cancer. En: JC Holland and JH Rowland, editor.New York: Oxford University Press; 1998.
  • Block SD. Assessing and managing depression in the terminally ill patient. ACPASIM End-of-Life Care Consensus Panel. American College of Physicians - American Society of Internal Medicine. Ann Intern Med. 2000;132(3):209-18.
  • Chochinov HM, Wilson KG, Enns M, Lander S. «Are you depressed?» Screening for depression in the terminally ill. Am J Psychiatry. 1997;154(5):674-6.
  • Carr DB, Goudas L, Lawrence D, et al. Management of cancer symptoms: pain, depression and fatigue.Evidence Report/technology Assessment Number 61. Prepared by the New England Medical Center Evidence-Based Practice Center under Contract No 290-97-0019). AHRQ Publication No. 02-E032. Rockville,MD:Agence for Healthcare Research and Quality; 2002.
  • Rodin G, Lloyd N, Katz M, Green E, Mackay JA, Wong RK. The treatment of depression in cancer patients: a systematic review. Support Care Cancer. 2007;15(2):123-36.
  • Sood A, Barton DL, Loprinzi CL. Use of methylphenidate in patients with cancer. American Journal of Hospice and Palliative Medicine. 2006;23(1):35-40.
  • Assessment, Evaluation, and Management of Suicidal Patients.Disponible en http://www.cancer.gov/cancertopics/pdq/supportivecare/depression/
    HealthProfessional/ page5    . PDQ® Cancer Information Summaries: Supportive Care. Depression (PDQ®). National Cancer Institute; 2007.
  • Keefe DM, Schubert MM, Elting LS, Sonis ST, Epstein JB, Raber-Durlacher JE, et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer. 2007;109(5):820-31.
  • Worthington H, Clarkson J, Eden O. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews. 2007;2.
  • Clarkson J, Worthington H, Eden O. Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews. 2007;2, 2007.
  • Oneschuk D, Hanson J, Bruera E, Oneschuk D, Hanson J, Bruera E. A survey of mouth pain and dryness in patients with advanced cancer.[see comment]. Supportive Care in Cancer. 2000;8(5):372-6.
  • Doyle D, Hanks G, Chreney N, Calman K. Oxford Textbook of Palliative Medicine. Third ed. Oxford: Oxford University Press; 2004. ss;
  • Symptomatic Treatment of Radiation-Induced Xerostomia in Head and Neck Cancer Patients. Practice Guideline Report # 5-5. Head & Neck Cancer Evidence- based Series and Practice Guidelines 2004 http://www.cancercare.on.ca/pdf/full5_1.pdf [Acceso Junio 2007]
  • von B, I, Sollecito TP, Fox PC, Daniels T, Jonsson R, Lockhart PB, et al. Salivary dysfunction associated with systemic diseases: systematic review and clinical management recommendations. [Review] [163 refs]. Oral Surgery Oral Medicine Oral Pathology Oral Radiology & Endodontics. 2007;103 Suppl:S57-15.
  • Davies A, Shorthose K. Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy. Cochrane Database Syst Rev. 2007;(3):CD003782.
  • De Conno F, Sbanotto A, Ripamonti C, Ventafrida V. Mouth care. In: Doyle D, Hanks G, Chreney N, Calman K, editors. Oxford Textbook of Palliative Medicine. Third ed. Oxford: Oxford University Press; 2004. p. 1117-33.
  • Watson MS, Lucas C.F, Hoy AM, Back IN. Gastrointestinal symptoms. Oxford Handbook of Palliative Care.New York: Oxford University press; 2005. p. 237-82.
  • Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, et al. Guidelines for treatment of candidiasis. Clin Infect Dis. 2004;38(2):161-89.
  • Pankhurst CL. Candidiasis (oropharyngeal). Clin Evid. 2006;(15):1849-63.
  • Clarkson J, Worthington H, Eden O. Interventions for preventing oral candidiasis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews. 2007;2, 2007.
  • Regnard C. Dysphagia, dyspepsia, and hiccup. In: Doyle D, Hanks G, Chreney N, Calman K, editors. Oxford Textbook of Palliative Medicine. Third ed. Oxford: Oxford University Press; 2004. p. 459-68.
  • Kris MG, Hesketh PJ, Somerfield MR, Feyer P, Clark-Snow R, Koeller JM, et al. American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006. J Clin Oncol. 2006;24(18):2932-47.
  • Ioannidis JP, Hesketh PJ, Lau J. Contribution of dexamethasone to control of chemotherapy-induced nausea and vomiting: a meta-analysis of randomized evidence. J Clin Oncol. 2000;18(19):3409-22.
  • Keeley PW. Nausea and vomiting in people with cancer and other chronic diseases. Clinical Evidence. London: BMJ Publishing Group; 2007. p. 1-12.
  • Jantunen IT, Kataja VV, Muhonen TT. An overview of randomised studies comparing 5-HT3 receptor antagonists to conventional anti-emetics in the prophylaxis of acute chemotherapy-induced vomiting. Eur J Cancer. 1997;33(1):66-74.
  • Poli-Bigelli S, Rodrigues-Pereira J, Carides AD, Julie MG, Eldridge K, Hipple A, et al. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America. Cancer. 2003;97(12):3090-8.
  • Tramer MR, Carroll D, Campbell FA, Reynolds DJ, Moore RA, McQuay HJ. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. BMJ. 2001;323(7303):16-21.
  • Tramer MR, Reynolds DJ, Stoner NS, Moore RA, McQuay HJ. Efficacy of 5-HT3 receptor antagonists in radiotherapy-induced nausea and vomiting: a quantitative systematic review. Eur J Cancer. 1998;34(12):1836-44.
  • Supportive Care & Symptom Control Regimens. Management of Chemotherapy- induced Nausea and Vomiting. Disponible en http://www.cancercare.on.ca/pdfchemo/NVguidelines pdf [accedido en: septiembre 2007]
  • Hoskin P. Radiotherapy in symptom management. In: Doyle D, Hanks G, Chreney N, Calman K, editors. Oxford Textbook of Palliative Medicine. Third ed. Oxford: Oxford University Press; 2004. p. 239-59.
  • Cancer care Ontario Practice Guidelines Initiative. Use of 5-HT3 receptor antagonists in patients receiving moderately or highly emetogenic chemotherapy. Disponible en: www cancercare on ca/ [accedido en: septiembre 2007] 2003
  • Glare P, Pereira G, Kristjanson LJ, Stockler M, Tattersall M. Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with faradvanced cancer. Support Care Cancer. 2004;12(6):432-40.
  • Critchley P, Plach N, Grantham M, Marshall D, Taniguchi A, Latimer E, et al. Efficacy of haloperidol in the treatment of nausea and vomiting in the palliative patient: A systematic review [3]. Journal of Pain & Symptom Management. 2001;22(2):631-4.
  • Aapro MS, Molassiotis A, Olver I. Anticipatory nausea and vomiting. Support Care Cancer. 2005;13(2):117-21.
  • Ahmedzai SH, Boland j. Constipation in people prescribed opioids. In: BMJ Publishing Group, editor. Clinical Evidence. London: 2007. p. 2407.
  • Sykes N. Constipation and diarrhoea. In: Doyle D, Hanks G, Chreney N, Calman K, editors. Oxford Textbook of Palliative Medicine. Third ed. Oxford: Oxford University Press; 2004. p. 483-96.
  • Miles CL, Fellowes D, Goodman ML, Wilkinson S. Laxatives for the management of constipation in palliative care patients. Cochrane Database Syst Rev. 2006;(4):CD003448.
  • Szilagyi A, Shrier I. Systematic review: the use of somatostatin or octreotide in refractory diarrhoea. Aliment Pharmacol Ther. 2001;15(12):1889-97.
  • Ripamonti C, Mercadante S. Pathophysiology and management of malignant bowel obstruction. In: Doyle D, Hanks G, Chreney N, Calman K, editors. Third ed. Oxford: Oxford University Press; 2004. p. 496-507.
  • Feuer DJ, Broadley KE. Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev. 2000;(2):CD001219.
  • Watt AMB, Faragher IGF, Griffin TTP, Rieger NAM, Maddern GJP. Selfexpanding Metallic Stents for Relieving Malignant Colorectal Obstruction: A Systematic Review. [Review]. Annals of Surgery. 2007;246(1):24-30.
  • Mercadante S, Casuccio A, Mangione S. Medical Treatment for Inoperable Malignant Bowel Obstruction: A Qualitative Systematic Review. Journal of Pain and Symptom Management. 2007;33(2):217-23.
  • Kichian K, Vain BG. Jaundice, ascites, and hepatic encephalopathy. In: Doyle D, Hanks G, Chreney N, Calman K, editors. Oxford Textbook of Palliative Medicine. Third ed. Oxford: Oxford University Press; 2004.
  • Reddy M, Gill SS, Rochon PA, Reddy M, Gill SS, Rochon PA. Preventing pressure ulcers: a systematic review. JAMA. 2006;296(8):974-84.
  • Cullum N, McInnes E, Bell-Syer SE, Legood R, Cullum N, McInnes E, et al. Support surfaces for pressure ulcer prevention.[see comment][update of Cochrane Database Syst Rev. 2000;(2):CD001735; PMID: 10796662]. [Review] [101 refs]. Cochrane Database of Systematic Reviews. 2004;(3):CD001735.
  • Royal College of Nursing and National Institute for Health and Clinical Excellence. The management of pressure ulcers in primary and secondary care A Clinical Practice Guideline. London: Royal College of Nursing; 2005.
  • Murtagh FE, ddington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis. 2007;14(1):82-99.
  • Heinrich WL. Uremic pruritus. In: UpToDate RB, editor. UpToDate. Waltham,MA: UpToDate; 2007.
  • Kaplan M, Chopra S. Pruritus associated with cholestasis. In: UpToDate RB, editor. UpToDate.Waltham,MA: UpToDate; 2007.
  • Twycross R, Greaves MW, Handwerker H, Jones EA, Libretto SE, Szepietowski JC, et al. Itch: scratching more than the surface. QJM. 2003;96(1):7-26.
  • Zylicz Z, Krajnik M, Sorge AA, Costantini M. Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. J Pain Symptom Manage. 2003;26(6):1105-12.
  • Zylicz Z, Stork N, Krajnik M. Severe pruritus of cholestasis in disseminated cancer: developing a rational treatment strategy. A case report. J Pain Symptom Manage. 2005;29(1):100-3.
  • Lidstone V, Thorns A. Pruritus in cancer patients. Cancer Treat Rev. 2001;27(5):305-12.
  • Khurana S, Singh P. Rifampin is safe for treatment of pruritus due to chronic cholestasis: a meta-analysis of prospective randomized-controlled trials. Liver Int. 2006;26(8):943-8.
  • Watson MS, Lucas C.F, Hoy AM, Back IN. Skin problems in palliative care. Oxford Handbook of Palliative Care. New York: Oxford University press; 2005.
  • Davis MP, Frandsen JL, Walsh D, Andresen S, Taylor S. Mirtazapine for pruritus. J Pain Symptom Manage. 2003;25(3):288-91.
  • Norman R, Bailly G. Genito-urinay problems in palliative medicine. In: Doyle D, Hanks G, Chreney N, Calman K, editors. Oxford Textbook of Palliative Medicine. Third ed. Oxford: Oxford University Press; 2004.
  • Agus Z.S, Berenson J.R. Treatment of hypercalcemia. In: UpToDate RB, editor. UpToDate.Waltham,MA: UpToDate; 2007.
  • Bower M, Cox S. Endocrine and metabolic complications of advanced cancer. In: Doyle D, Hanks G, Chreney N, Calman K, editors. Oxford Textbook of Palliative Medicine. Third ed. Oxford: Oxford University Press; 2004.
  • Saunders Y, Ross JR, Broadley KE, Edmonds PM, Patel S. Systematic review of bisphosphonates for hypercalcaemia of malignancy. Palliat Med. 2004;18(5):418-31.
  • Watson MS, Lucas C.F, Hoy AM, Back IN. Emergencies in palliative care. Oxford Handbook of Palliative Care. New York: Oxford University press; 2005.
  • Loblaw DA, Perry J, Chambers A, Laperriere NJ. Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the Cancer Care Ontario Practice Guidelines Initiative’s Neuro-Oncology Disease Site Group. J Clin Oncol. 2005;23(9):2028-37.
  • Klimo P, Jr., Thompson CJ, Kestle JRW, Schmidt MH. A meta-analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease. Neuro-oncol. 2005;7(1):64-76.
  • Patchell RA, Tibbs PA, Regine WF, Payne R, Saris S, Kryscio RJ, et al. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial. Lancet. 2005;366(9486):643-8.
  • Cock HR, Schapira AH. A comparison of lorazepam and diazepam as initial therapy in convulsive status epilepticus. QJM. 2002;95(4):225-31.
  • Alldredge BK, Gelb AM, Isaacs SM, Corry MD, Allen F, Ulrich S, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-ofhospital status epilepticus. N Engl J Med. 2001;345(9):631-7.
  • Caraceni A, Martini C, Simonetti F. Neurological problems in advanced cancer. In: Doyle D, Hanks G, Chreney N, Calman K, editors. Oxford Textbook of Palliative Medicine. Third ed. Oxford: Oxford University Press; 2004. p. 703-26.
  • Dreifuss FE, Rosman NP, Cloyd JC, Pellock JM, Kuzniecky RI, Lo WD, et al. A comparison of rectal diazepam gel and placebo for acute repetitive seizures. N Engl J Med. 1998;338(26):1869-75.
  • Milligan NM, Dhillon S, Griffiths A, Oxley J, Richens A. A clinical trial of single dose rectal and oral administration of diazepam for the prevention of serial seizures in adult epileptic patients. J Neurol Neurosurg Psychiatry. 1984;47(3):235-40.
  • Rees J. Fits. In: Sykes N, Edmonds P, Wiles J, editors. Management of advanced disease. Fourth ed. London: Arnold; 2004. p. 240-9. 4.
  • Sirven JI, Wingerchuk DM, Drazkowski JF, Lyons MK, Zimmerman RS. Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin Proc. 2004;79(12):1489-94.
  • Gagnon B, Mancini I, Pereira J, Bruera E. Palliative management of bleeding events in advanced cancer patients. J Palliat Care. 1998;14(4):50-4.
  • Pereira J, Phan T. Management of bleeding in patients with advanced cancer. Oncologist. 2004;9(5):561-70.
  • Prommer E. Management of bleeding in the terminally ill patient. Hematology. 2005;10(3):167-75.
  • Uitterhoeve RJ, Vernooy M, Litjens M, Potting K, Bensing J, De MP, et al. Psychosocial interventions for patients with advanced cancer - A systematic review of the literature. British Journal of Cancer. 2004;91(6):1050-62.
  • Newell SA, Sanson-Fisher RW, Savolainen NJ. Systematic Review of Psychological Therapies for Cancer Patients: Overview and Recommendations for Future Research. J Natl Cancer Inst. 2002;94(8):558-84.
  • Payne S, Kerr C, Hawker S, Hardey M, Powell J. The communication of information about older people between health and social care practitioners. Age Ageing. 2002;31(2):107-17.
  • Lin HR, Bauer-Wu SM. Psycho-spiritual well-being in patients with advanced cancer: an integrative review of the literature. J Adv Nurs. 2003;44(1):69-80.
  • Bayés Sopena R, Borràs Hernández FX. ¿Qué son las necesidades espirituales? Medicina Paliativa. 2005;12(2):99-107.
  • Holloway M. Death the great leveller? Towards a transcultural spirituality of dying and bereavement. J Clin Nurs. 2006;15(7):833-9.
  • Harding R, Higginson IJ. What is the best way to help caregivers in cancer and palliative care? A systematic literature review of interventions and their effectiveness. Palliat Med. 2003;17(1):63-74.
  • Stoltz P, Uden G, Willman A. Support for family carers who care for an elderly person at home - A systematic literature review 10. Scand J Caring Sci. 2004; 18(2).
  • Grov EK, Dahl AA, Moum T, Fossa SD, Grov EK, Dahl AA, et al. Anxiety, depression, and quality of life in caregivers of patients with cancer in late palliative phase. Annals of Oncology. 2005;16(7):1185-91.
  • Proot IM, bu-Saad HH, Crebolder HF, Goldsteen M, Luker KA, Widdershoven GA, et al. Vulnerability of family caregivers in terminal palliative care at home; balancing between burden and capacity. Scand J Caring Sci. 2003;17(2):113-21.
  • Fürst CJ, Doyle D. The terminal phase. In: Doyle D, Hanks G, Chreney N, Calman K, editors. Oxford Textbook of Palliative Medicine. Third ed. Oxford: Oxford University Press; 2004. p. 1117-33.
  • Ellershaw J, Ward C. Care of the dying patient: the last hours or days of life. BMJ. 2003;326(7379):30-4.
  • Oi-Ling K, Man-Wah DT, Kam-Hung DN. Symptom distress as rated by advanced cancer patients, caregivers and physicians in the last week of life. Palliat Med. 2005;19(3):228-33.
  • Wildiers H, Menten J. Death Rattle: Prevalence, Prevention and Treatment. Journal of Pain and Symptom Management. 2002;23(4):310-7.
  • Sedación en cuidados paliativos. Grupo de trabajo de Tratamientos del Programa Regional de Cuidados Paliativos del Servicio Extremeño de Salud. 2006 http://www.secpal.com/guiasm/index.php?acc=see_guia&id_guia=8
  • Morita T, Bito S, Kurihara Y, Uchitomi Y. Development of a clinical guideline for palliative sedation therapy using the Delphi method. J Palliat Med. 2005;8(4):716-29.
  • Barbero J. Sufrimiento, cuidados paliativos y responsabilidad moral. In: Couceiro A, editor. Ética en Cuidados Paliativos.Madrid: Editorial Triacastela; 2004. p. 426-7.
  • Morita T, Tsuneto S, Shima Y. Definition of sedation for symptom relief: A systematic literature review and a proposal of operational criteria. Journal of Pain & Symptom Management. 2002;24(4):447-53.
  • Cowan JD, Walsh D. Terminal sedation in palliative medicine--definition and review of the literature. Support Care Cancer. 2001;9(6):403-7.
  • Porta-Sales J. Sedación paliativa. In: Porta-Sales J, Gomez-Batiste X, Tuca A, editors. Manual de control de síntomas en pacientes con cáncer avanzado y terminal.Madrid: Editorial Arán; 2004. p. 259-70.
  • Landa V, García-García J. Duelo.Fisterra.Guias Clínicas. 2007;7 (26). Disponible en http://www.fisterra.com [Acceso Julio 2007].
  • Dohrenwend BS, Krasnoff L, Askenasy AR, Dohrenwend BP. The Psychiatric Epidemiology Research Interview Life Events Scale. En: Mezzich JE, Jorge MR, Salloum IM, editors. Psychiatric Epidemiology.Baltimore: The Johns Hopkins University Press; 1994. p. 401-36.
  • Holmes TH, Rahe TH. The Social Readjustment Rating Scale. J Psychosom Res. 2007;11:213-8.
  • Genevro Jl, Marshall T, Miller T. Report on Bereavement an Grief Research. Washington DC: Center for the Advancement of Health. Disponible en: http://www.cfah.org/pdfs/griefreport.pdf [Acceso Julio 2007].
  • Aranda S, Milne D. Guidelines for the assessment of bereavement risk in family members of people receiving palliative care. Melbourne: Centre for Pallaitive Care; 2000.
  • Kristjanson L, Lobb E, Aoun S. A systematic review of the literature on complicated grief. Disponible en http://www.health.gov.au/ Australia: Australian Government, Department of Health and Ageing [Acceso Julio 2007].
  • Prigerson HG, Vanderwerker LC, Maciejewski PK. Prolonged Grief Disorder: a case for inclusión in DSM-V. In: Stroebe M, Hansson M, Schut H, Stroebe W, editors. Handbook of Bereavement Research and Practice:21 Century Perspectives. Washington DC: American Psycological Association Press; 2007.
  • Allumbaugh DL, Hoyt W. Effectiveness of grief therapy:a meta-analysis. J Couns Psychol. 1999;46:370-80.
  • Fortner B. The effectiveness of grief counseling and therapy: a quantitative review [Tesis doctoral] Memphis University; 1999.
  • Wimpenny P, Unwin R, Dempster P, Grundy M, Work F, Brown A, et al. Literature review on bereavement and bereavement care [Internet]. Aberdeen; 2006.
  • Watson MS, Lucas C.F, Hoy AM, Back IN. Oxford Handbook of Palliative Care. New York: Oxford University press; 2005.
  • Pascual A, Subirana M. Guia de pràctica clínica per a látenció pal.liativa al malat en fase terminala l’hospital de la Santa creu i Sant Pau. Barcelona; 2005.
  • Sanz Ortiz J, Gomez-Batiste X, Gómez Sancho M, Nuñez-Olarte JM. Manual de cuidados paliativos. Recomendaciones de la Sociedad española de Cuidados Paliativos (SECPAL). Madrid: Guías y Manuales del Ministerio de Sanidad y Consumo. Ministerio de Sanidad y Consumo. Secretaria General Técnica; 1993.
  • SIGN. A guideline developers’ handbook . Edinburgh: Scottish Intercollegiate Guidelines Network (SIGN); 2001.
  • Oxford Centre for Evidence-based Medicine. Levels of Evidence and Grades of Recommendation. Disponible en http://www.cebm.net/levels_of_evidence.asp [Acceso Octubre 2005].
  • Higginson IJ. Evidence based palliative care. There is some evidence-and there needs to be more. BMJ. 1999;319(7208):462-3.
  • Aoun SM, Kristjanson LJ. Evidence in palliative care research: How should it be gathered? Med J Aust. 2005;183(5):264-6.
You are here Bibliografía Cuidados Paliativos